Gadolinium is not the only trigger for nephrogenic systemic fibrosis: Insights from two cases and review of the recent literature

93Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Nephrogenic systemic fibrosis (NSF) is an emerging fibrosing disease with serious consequences in patients with acute and chronic kidney disease including solid organ and renal transplant recipients. It has recently been linked to gadolinium exposure. Almost all recently reported cases of NSF were found to be preceded by gadolinium administration, which led the FDA to issue a warning against the use of gadolinium in patients with moderate-to-severe reduction in the glomerular filtration rate. We report two organ transplant recipients who developed NSF and in whom extensive record review failed to document any prior gadolinium exposure. We then critically review the recently published literature linking NSF and gadolinium and we propose other possible triggers. We conclude that gadolinium is not the only trigger for NSF, and that the search for other triggers should be sought. We believe that this information is an important addition to the NSF literature, such that the definitive etiology and pathogenesis of NSF can be researched. © 2007 The Authors.

References Powered by Scopus

Gadolinium - A specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

1668Citations
N/AReaders
Get full text

Nephrogenic systemic fibrosis: Suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging

1244Citations
N/AReaders
Get full text

Nephrogenic systemic fibrosis: Risk factors and incidence estimation

839Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: A summary of the medical literature reporting

251Citations
N/AReaders
Get full text

Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions

182Citations
N/AReaders
Get full text

MRI safety update 2008: Part 1, MRI contrast agents and nephrogenic systemic fibrosis

173Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Wahba, I. M., Simpson, E. L., & White, K. (2007, October). Gadolinium is not the only trigger for nephrogenic systemic fibrosis: Insights from two cases and review of the recent literature. American Journal of Transplantation. https://doi.org/10.1111/j.1600-6143.2007.01941.x

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

55%

Researcher 3

27%

Professor / Associate Prof. 1

9%

Lecturer / Post doc 1

9%

Readers' Discipline

Tooltip

Medicine and Dentistry 13

81%

Computer Science 1

6%

Chemistry 1

6%

Nursing and Health Professions 1

6%

Save time finding and organizing research with Mendeley

Sign up for free